C3i has built a one-stop shop in the development chain of Cell & Gene Therapy.
We work closely with our clients to manufacture products destined for patients all over the world. C3i prides itself on delivering, on time, quality results on behalf of its clients and for patients, advanced cell and gene products that meet regulatory requirements around the world.
We are an extension of your team
C3i works as part of your team proudly blurring the lines between “you“ and “us” to the most desirable “we.” We are the CDMO for cell and gene therapy that fills the gap between your research and innovative patient therapies.
Read the latest news
Sep 20, 2023
CDMO C3i Center Inc Located in Montreal, Canada Has Begun Manufacturing a Cell Therapy Product for Europe.Read More
The Montreal-based CDMO C3i Center Inc is paving the way in the cell and gene therapy industry in North American and Canada as one of a few contract development and manufacturing organizations (CDMOs) to be producing in North America and for Europe. “We are proud of our team has worked very hard to be able […]
Aug 07, 2023
C3i is proud to sponsor Meeting on the MESA 23, North America’s leading gathering of experts and leaders in the cell and gene therapy sector.Read More
C3i is a platinum sponsor for the Alliance for Regenerative Medicine’s 2023 Cell and Gene Meeting on the Mesa from October 10 – 12, 2023. We look forward to connecting with senior executives and top stakeholders to tackle the most pressing issues in cell and gene therapies. To learn more about this event: https://meetingonthemesa.com/ See […]
Jan 10, 2022
C3i Profiled in Outsourced PharmaRead More
C3i CEO Louisa Petropoulos was recently featured in Outsourced Pharma online, discussing the present and future prospects of contract research organizations and Canadian innovation, as well as C3i’s accomplishments upon its 5th anniversary. Click here to read the story.